KAPA

KAIROS PHARMA LTD

• TipRanks·5d ago

  Analysts Are Bullish on Top Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Actinium Pharmaceuticals (ATNM)

• Benzinga·03/31 22:37

  Kairos Pharma Q4 EPS $(0.07) Beats $(0.10) Estimate

• TipRanks·03/11 11:05

  Expanding Lung Cancer Franchise and Strategic Asset Acquisition Support Buy Rating on Kairos Pharma

• TipRanks·03/11 11:00

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Pfizer (PFE) and Medtronic (MDT)

• TipRanks·03/02 12:19

  Kairos Pharma Acquires Rights to AI-Discovered EGFR Therapy

• TipRanks·03/02 11:53

  Kairos Pharma to acquire CL-273 from Celyn Therapeutics

• Benzinga·03/02 11:32

  Kairos Pharma Enters Into Binding Terms To Acquire CL-273 From Celyn Therapeutics For Undisclosed Sum; Transaction Is Expected To Be Value‑Accretive

• NASDAQ·02/27 14:17

  Weekly Buzz: MGNX's LINNET Trial On Hold; ETON, ALUR Get FDA Nod; GILD Snaps Up ACLX

• NASDAQ·02/27 01:53

  Kairos Pharma Signs Term Sheet To Acquire Two Oncology Assets From Celyn Therapeutics; Stock Up

• Benzinga·02/26 21:05

  12 Health Care Stocks Moving In Thursday's After-Market Session

• TipRanks·02/26 14:24

  Kairos Pharma to acquire to two clinical-stage oncology assets from Celyn

• TipRanks·02/26 12:50

  Kairos Pharma Expands Lung Cancer Pipeline With Celyn Deal

• Benzinga·02/26 12:14

  Kairos Pharma Signs Deal To Acquire Two Experimental Lung Cancer Drug Candidates, Financial Terms Undisclosed

• Benzinga·02/26 12:05

  12 Health Care Stocks Moving In Thursday's Pre-Market Session

• Dow Jones·02/26 12:04

  *Kairos Pharma: Transaction to Add CL-273, a pan-EGFR Inhibitor, and CL-741, a Phase 1-Ready c-MET Inhibitor >KAPA